The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
2-(tert-Butoxy)-2-(5-methyl-2-phenyl-7-(m-tolyl)pyrazolo-[1,5-a]pyrimidin-6-yl)acetic Acid ID: ALA4475105
PubChem CID: 70660283
Max Phase: Preclinical
Molecular Formula: C26H27N3O3
Molecular Weight: 429.52
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: Cc1cccc(-c2c(C(OC(C)(C)C)C(=O)O)c(C)nc3cc(-c4ccccc4)nn23)c1
Standard InChI: InChI=1S/C26H27N3O3/c1-16-10-9-13-19(14-16)23-22(24(25(30)31)32-26(3,4)5)17(2)27-21-15-20(28-29(21)23)18-11-7-6-8-12-18/h6-15,24H,1-5H3,(H,30,31)
Standard InChI Key: VLWISWDZAAGZQS-UHFFFAOYSA-N
Molfile:
RDKit 2D
32 35 0 0 0 0 0 0 0 0999 V2000
35.8004 -5.8105 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
36.5179 -5.3990 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.5151 -4.5679 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.7986 -4.1564 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.0846 -5.3994 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.0859 -4.5746 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
34.3015 -4.3197 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
33.8139 -4.9830 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.2996 -5.6517 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.9882 -4.9863 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.5791 -4.2686 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.7543 -4.2670 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.3377 -4.9824 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.7559 -5.7009 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.5793 -5.6989 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.2298 -5.8084 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.2248 -4.1504 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.9419 -4.5625 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.6558 -4.1450 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
37.9450 -5.3880 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
37.2218 -3.3249 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
37.9356 -2.9115 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.9326 -2.0859 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.6527 -3.3194 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.6466 -2.4890 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.7935 -3.3361 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.5087 -2.9228 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.5011 -2.0980 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.7874 -1.6857 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.0714 -2.1082 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.0784 -2.9316 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.3564 -1.7039 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5 1 1 0
1 2 2 0
2 3 1 0
3 4 2 0
4 6 1 0
5 6 1 0
6 7 1 0
7 8 2 0
8 9 1 0
9 5 2 0
10 11 2 0
11 12 1 0
12 13 2 0
13 14 1 0
14 15 2 0
15 10 1 0
8 10 1 0
2 16 1 0
3 17 1 0
17 18 1 0
18 19 1 0
18 20 2 0
17 21 1 0
21 22 1 0
22 23 1 0
22 24 1 0
22 25 1 0
26 27 2 0
27 28 1 0
28 29 2 0
29 30 1 0
30 31 2 0
31 26 1 0
4 26 1 0
30 32 1 0
M END Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 429.52Molecular Weight (Monoisotopic): 429.2052AlogP: 5.62#Rotatable Bonds: 5Polar Surface Area: 76.72Molecular Species: ACIDHBA: 5HBD: 1#RO5 Violations: 1HBA (Lipinski): 6HBD (Lipinski): 1#RO5 Violations (Lipinski): 1CX Acidic pKa: 3.93CX Basic pKa: 1.37CX LogP: 5.52CX LogD: 2.32Aromatic Rings: 4Heavy Atoms: 32QED Weighted: 0.45Np Likeness Score: -1.07
References 1. Li G, Meanwell NA, Krystal MR, Langley DR, Naidu BN, Sivaprakasam P, Lewis H, Kish K, Khan JA, Ng A, Trainor GL, Cianci C, Dicker IB, Walker MA, Lin Z, Protack T, Discotto L, Jenkins S, Gerritz SW, Pendri A.. (2020) Discovery and Optimization of Novel Pyrazolopyrimidines as Potent and Orally Bioavailable Allosteric HIV-1 Integrase Inhibitors., 63 (5): [PMID:32081010 ] [10.1021/acs.jmedchem.9b01681 ]